Marijuana Laws, Regulations, & Politics | MJ Shareholders

Member Spotlight: RoseRyan

California Marijuana Laws, Regulations, & Politics October 29, 2018 0

In this month’s member spotlight we caught up with Maureen Ryan of RoseRyan, a finance and accounting consulting firm based in Silicon Valley that officially launched its cannabis solution this April. Finance is the language of business, and her firm, since 1993, has helped hundreds of companies get their financial... Read more

Academia joins CBD research boom, offering new market opportunities

Featured Industrial Hemp News Marijuana Laws, Regulations, & Politics October 26, 2018 0

Lack of significant research on the effect of cannabinoids has long been a bane to the CBD and hemp industries. But in the wake of the U.S. Drug Enforcement Administration’s decision to reschedule some cannabis-derived products, researchers are looking for ways to open and capitalize on new markets and... Read more

Member Blog: Common Cannabis Capital Cadence

Marijuana Laws, Regulations, & Politics October 26, 2018 0

by Sumit Mehta, CEO of MAZAKALINCIA’s Finance and Insurance Committee Companies often benefit from capital infusions that can help them grow their businesses. When and how much capital to raise is a common question, once that is best addressed by balancing need for cash with dilution of equity. This... Read more

Canadian cannabis company adds Polish hemp grower to European portfolio

Industrial Hemp News International News Marijuana Laws, Regulations, & Politics October 25, 2018 0

A Canadian cannabis company has bought a Polish hemp firm to expand CBD production in Europe. International Cannabis Corp. (ICC) announced Tuesday that it has acquired Polannabis Holdings, which includes a company that grows 850 acres of hemp and has licenses to extract CBD. ICC is paying 2.5 million... Read more

Campaign Blog: Vote Yes on North Dakota Measure 3

Marijuana Laws, Regulations, & Politics North Dakota Uncategorized October 25, 2018 0

by David Owen, Chairman of Legalize North Dakota What Measure 3 does is rather simple. It removes marijuana from the list of Schedule 1 Substances, and as a result, legalizes it for personal consumption, use, distribution, and possession for all North Dakotans over the age of 21. Additionally, it... Read more

Capitalizing on CBD: New market opportunities with athletes

Featured Industrial Hemp News Marijuana Laws, Regulations, & Politics October 25, 2018 0

(This is an abridged version of a story that appears in the September issue of Marijuana Business Magazine.) Athletes have long used cannabis products to fight inflammation and recover from injury, but drug-testing rules and marijuana stigma have often kept it a locker-room secret. That’s all changing now, thanks to... Read more

‘One day you’re legal, the next day you’re not’: Confusion from spotty CBD enforcement

Featured Industrial Hemp News Marijuana Laws, Regulations, & Politics October 25, 2018 0

CBD producers and retailers in some of the nation’s largest markets say they’re pressing on despite hostile statements from their state regulators that CBD won’t be allowed. Bans in several markets have largely been met with spotty enforcement, CBD entrepreneurs say, and the impact to business has been mixed.... Read more

When cannabis isn’t cannabis – and why hemp may suffer for it

Featured Industrial Hemp News Marijuana Laws, Regulations, & Politics October 24, 2018 0

(This is an abridged version of a column that appears in the October issue of Marijuana Business Magazine.) How’s this for irony? The hemp industry’s rush to distance itself from marijuana has gone so far that hemp products can’t be sold in the world’s largest cannabis economy. The development in... Read more

RI allows medical marijuana to treat autism – after trying FDA-approved CBD

Industrial Hemp News Marijuana Laws, Regulations, & Politics October 22, 2018 0

A Rhode Island decision to expand medical marijuana access has a worrying caveat for many in the CBD industry: Patients must first try an FDA-approved version of the drug. That classification by the Food and Drug Administration is currently limited to Epidiolex, an epilepsy treatment made by United Kingdom-based pharmaceutical... Read more

Chart: Opportunity in CBD-only stores limited, but strong growth expected for other channels

Featured Industrial Hemp News Marijuana Laws, Regulations, & Politics October 18, 2018 0

As state laws around cannabidiol continue to change, stand-alone CBD stores may become a relic. According to estimates from Hemp Industry Daily in the 2018 Hemp & CBD Industry Factbook, CBD sales in the U.S. are expected to exceed $1 billion by 2020. More than half (55%) of retail respondents to a survey for... Read more